查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1796758

全球強迫症藥物市場報告：趨勢、預測和競爭分析（至2031年）

Obsessive-Compulsive Disorder Medicine Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球強迫症藥物市場前景光明，得益於醫院、居家醫療和診所市場的機會。預計2025年至2031年期間，全球強迫症藥物市場規模的年複合成長率將達到7.3%。這個市場的主要驅動力是人們對強迫症的認知不斷提高以及精神疾病盛行率的上升。

  • Lucintel 預測，在預測期內，抗憂鬱症將成為藥物類型中成長最快的藥物。
  • 以用途類型來看，醫院預計將出現最高的成長。
  • 依地區分類，預計亞太地區將在預測期內實現最高成長。

強迫症治療市場的新趨勢

隨著目的是提高治療效果和患者可及性的新趨勢的出現，強迫症藥物市場快速發展。藥物治療、數位醫療工具和整合照護模式的進步塑造強迫症治療的未來。這些趨勢為改善患者治療效果和提升護理品質提供了充滿希望的途徑。

  • 新型藥物治療的應用：新藥不斷湧現，目的是更有效地治療強迫症。近期核准用於治療難治性強迫症的esketamine等藥物，為對 SSRI 類藥物無反應的患者提供了一種新治療方法。這些藥物，以及第二代抗精神病藥物和SNRI等其他藥物，拓展治療選擇，尤其適用於第一線藥物治療未見顯著改善的患者。這種多樣化的治療方法重塑強迫症的治療方式，並為那些一直難以忍受傳統藥物治療的患者帶來希望。
  • 認知行為療法（CBT）與藥物治療的整合：在強迫症治療中，藥物療法與認知行為療法（CBT），尤其是暴露與反應預防療法（ERP）的整合日益成為一種趨勢。研究表明，將這兩種療法結合起來比單純藥物治療更有效。美國和德國等國的醫療保健提供者將 CBT 納入其標準治療通訊協定，並認知到在藥物治療症狀的同時，解決強迫症根本病因的重要性。
  • 數位健康工具和遠端醫療：數位工具和遠端醫療徹底改變強迫症的治療方式。行動應用程式、虛擬認知行為療法（CBT）和線上治療課程使患者能夠遠距接受治療，改善了醫療服務可近性，尤其惠及醫療資源匱乏地區的患者。此外，穿戴式裝置也已開發出來，用於追蹤症狀並提供即時回饋，實現更佳的強迫症管理。這些技術有助於彌合患者與醫療服務提供者之間的差距，並確保持續的監測和支援。
  • 著重個人化醫療：個人化醫療正成為強迫症治療的重要趨勢。透過分析遺傳、生物和心理因素，醫療保健提供者為每位患者制定個人化的治療方案。個人化治療方案會考慮每位患者對不同藥物的反應，確保更有針對性的治療和更高的療效。這種方法對於對標準藥物無效的難治性強迫症病例尤其有效。
  • 提高認知度，減少污名化：隨著人們對包括強迫症在內的心理健康問題的認知不斷提高，圍繞強迫症的污名化現象顯著減少。這項改變促使更多人接受治療，也促進了強迫症藥物市場的蓬勃發展。政府舉措、非營利組織和媒體宣傳活動提高了公眾對強迫症的認知，促進了早期診斷並改善了治療方法的可及性。

這些新興趨勢透過提供更有效、個人化且更便利的治療方案，改變強迫症治療市場。隨著新藥、數位醫療工具和整合照護模式的發展，強迫症治療領域正變得更加以患者為中心，為強迫症患者提供更好的機會。

強迫症治療市場的最新發展

近年來，強迫症藥物市場取得了多項重大進展，為患者提供了更豐富的治療選擇。這些進展包括新藥核准、治療技術的進步以及治療可近性的提升，所有這些都有助於改善患者的治療效果。

  • esketamine核准用於難治性強迫症：esketamine核准用於難治性強迫症，標誌著強迫症藥物市場的重大進展。esketamine透過鼻噴霧給藥，為對傳統SSRI或其他第一線藥物無效的患者提供了一種替代療法。這次核准為嚴重強迫症的治療開闢了新的可能性，並填補了現有治療方案的重大空白。
  • 個人化治療的進展：個人化醫療也應用於強迫症治療。透過考慮遺傳因素、先前治療反應以及合併症，醫療保健提供者可以提供更具針對性的治療方案。這種個人化方法對於難治性強迫症尤其有效，因為傳統藥物對此類強迫症無效。這一趨勢有望改善治療效果，並減少患者的試驗。
  • 數位健康解決方案的成長：症狀管理應用程式和虛擬認知行為療法（CBT）等數位健康工具擴大強迫症（OCD）治療的可及性。這些工具使患者能夠遠端獲得支持，為那些難以接受面對面治療的患者提供了便捷有效的選擇。這一發展尤其有利於居住在心理健康服務有限的農村和貧困地區的人們。
  • 新藥治療的出現：第二代抗精神病藥物Aripiprazole等新藥的問世，擴大了強迫症的治療方法。這些藥物通常與SSRI合併使用，有望減輕強迫症症狀，尤其是在較嚴重的病例中。這些新療法的開發為醫生提供了更多工具來治療各類強迫症患者。
  • 改善心理健康服務的可近性：隨著人們意識的提高和對心理健康服務的改善，世界各地強迫症治療的可近性不斷提升。各國政府和醫療機構努力透過提供資金、擴大保險覆蓋範圍和培訓更多心理健康專業人員來減少治療障礙。擴大治療可近性對於應對日益增加的強迫症患者尋求治療的需求非常重要。

這些關鍵進展使患者更容易找到有效的強迫症治療方法。隨著新藥、個人化治療策略和數位健康解決方案的推出，患者擁有比以往更多的選擇。這些進展改善強迫症患者的治療效果，並擴大其治療管道。

目錄

第1章 執行摘要

第2章 市場概述

  • 背景和分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 宏觀經濟趨勢與預測
  • 產業驅動力與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球強迫症治療市場（依類型）

  • 概述
  • 依類型的吸引力分析
  • NMDA 受體阻斷劑：趨勢與預測（2019-2031）
  • 抗精神病藥物：趨勢與預測（2019-2031）
  • 抗憂鬱症：趨勢與預測（2019-2031）

第5章 全球強迫症治療市場（依應用）

  • 概述
  • 依用途的吸引力分析
  • 醫院：趨勢與預測（2019-2031）
  • 居家醫療：趨勢與預測（2019-2031）
  • 醫療診所：趨勢與預測（2019-2031）
  • 其他：趨勢與預測（2019-2031）

第6章 區域分析

  • 概述
  • 全球強迫症治療市場（依地區）

第7章 北美強迫症藥物市場

  • 概述
  • 北美強迫症治療市場（依類型）
  • 北美強迫症治療市場（依應用）
  • 美國強迫症治療市場
  • 墨西哥強迫症治療市場
  • 加拿大強迫症藥物市場

第8章 歐洲強迫症藥物市場

  • 概述
  • 歐洲強迫症治療市場（依類型）
  • 歐洲強迫症治療市場（依應用）
  • 德國強迫症藥物市場
  • 法國強迫症藥物市場
  • 西班牙強迫症藥物市場
  • 義大利強迫症藥物市場
  • 英國強迫症藥物市場

第9章 亞太地區強迫症藥物市場

  • 概述
  • 亞太地區強迫症治療市場（依類型）
  • 亞太地區強迫症治療市場（依應用）
  • 日本強迫症治療市場
  • 印度強迫症治療市場
  • 中國強迫症藥物市場
  • 韓國強迫症治療市場
  • 印尼強迫症治療市場

第10章 世界其他地區強迫症藥物市場

  • 概述
  • 世界其他地區強迫症治療市場（依類型）
  • 世界其他地區強迫症治療市場（依應用）
  • 中東強迫症治療市場
  • 南美洲強迫症治療市場
  • 非洲強迫症藥物市場

第11章 競爭分析

  • 產品系列分析
  • 運作整合
  • 波特五力分析
    • 競爭敵對
    • 買方的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市場佔有率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 依類型分類的成長機會
    • 依應用分類的成長機會
  • 全球強迫症治療市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 合併、收購、協議、合作和合資企業

第13章 價值鏈主要企業概況

  • 競爭分析
  • Sun Pharmaceuticals Industry
  • H.Lunderbeck A/S
  • Eli Lilly And Company
  • Apotex
  • Viatris
  • Lannett
  • GlaxoSmithKline
  • Alvogen
  • Pfizer
  • Amneal Pharmaceuticals

第14章 附錄

  • 圖表一覽
  • 表格一覽
  • 調查方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於 Lucintel
  • 詢問

The future of the global obsessive-compulsive disorder medicine market looks promising with opportunities in the hospitals, homecare, and clinics markets. The global obsessive-compulsive disorder medicine market is expected to grow with a CAGR of 7.3% from 2025 to 2031. The major drivers for this market are the increasing awareness of OCD and the rising incidence of mental health conditions.

  • Lucintel forecasts that, within the type category, antidepressants are expected to witness the highest growth over the forecast period.
  • Within the application category, hospitals are expected to witness the highest growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Obsessive-Compulsive Disorder Medicine Market

The obsessive-compulsive disorder medicine market is evolving rapidly with the emergence of new trends that aim to improve treatment efficacy and patient access. Advances in pharmaceutical therapies, digital health tools, and integrated care models are shaping the future of OCD treatment. These trends offer promising avenues for improving patient outcomes and enhancing the quality of care.

  • Use of Novel Pharmacological Treatments: New medications are being introduced to target OCD more effectively. Drugs such as esketamine, which was recently approved for treatment-resistant OCD, are offering a new approach for patients who do not respond to SSRIs. These medications, along with others like second-generation antipsychotics and SNRIs, are improving treatment options, especially for individuals who have not seen significant improvement with first-line therapies. This growing variety of treatments is reshaping how OCD is managed and offers hope for patients who have struggled with traditional medications.
  • Integration of Cognitive Behavioral Therapy (CBT) with Medications: A growing trend in the treatment of OCD is the integration of pharmacological treatments with cognitive behavioral therapy (CBT), particularly exposure and response prevention (ERP). Studies have shown that combining these two approaches leads to more effective outcomes than using medications alone. Healthcare providers in countries like the U.S. and Germany are incorporating CBT as part of the standard treatment protocol, recognizing its role in addressing the root causes of OCD while medications manage the symptoms.
  • Digital Health Tools and Telemedicine: Digital tools and telemedicine are revolutionizing the way OCD is treated. Mobile apps, virtual CBT programs, and online therapy sessions allow patients to access treatment remotely, improving access to care, especially for those in underserved areas. In addition, wearable devices are being developed to track symptoms, providing real-time feedback and enabling better management of OCD. These technologies are helping to bridge the gap between patients and healthcare providers, ensuring continuous monitoring and support.
  • Focus on Personalized Medicine: Personalized medicine is becoming a key trend in OCD treatment. By analyzing genetic, biological, and psychological factors, healthcare providers are developing more customized treatment plans for each patient. Personalized approaches consider how individual patients respond to various medications, ensuring more precise treatment and improving efficacy. This approach is particularly useful in cases of treatment-resistant OCD, where patients have not responded well to standard medications.
  • Increase in Awareness and Reduced Stigma: As awareness of mental health issues increases, including OCD, there has been a significant reduction in the stigma surrounding the condition. This shift is encouraging more people to seek treatment, thereby expanding the market for OCD medicines. Government initiatives, non-profit organizations, and media campaigns are working to improve public understanding of OCD, leading to better early diagnosis and improved access to treatment options.

These emerging trends are transforming the OCD medicine market by offering more effective, personalized, and accessible treatments. With the development of novel drugs, digital health tools, and integrated care models, the landscape of OCD treatment is becoming more patient-centric, providing better opportunities for those living with the disorder.

Recent Developments in the Obsessive-Compulsive Disorder Medicine Market

The obsessive-compulsive disorder medicine market has witnessed several key developments in recent years that are improving the treatment options available to patients. These developments include new drug approvals, advancements in therapy techniques, and increased access to care, all of which contribute to better patient outcomes.

  • Approval of Esketamine for Treatment-Resistant OCD: The approval of esketamine as a treatment for patients with treatment-resistant OCD represents a major development in the OCD medicine market. Esketamine, delivered via a nasal spray, offers an alternative for patients who have not responded to traditional SSRIs and other first-line treatments. This approval opens up new possibilities for treating severe cases of OCD and addresses a significant gap in the available treatment options.
  • Advances in Personalized Treatment Approaches: Personalized medicine is making its way into the OCD treatment landscape. By considering factors like genetics, previous treatment responses, and co-occurring disorders, healthcare providers can offer more tailored treatment plans. Personalized approaches are particularly beneficial for treatment-resistant OCD, where traditional medications may not be effective. This trend is expected to enhance treatment outcomes and reduce the trial-and-error process for patients.
  • Growth of Digital Health Solutions: Digital health tools, such as apps for managing symptoms and virtual CBT programs, are expanding access to treatment for OCD. These tools allow patients to receive support remotely, offering a convenient and effective alternative for those who may not have easy access to in-person therapy. This development is particularly beneficial for individuals in rural or underserved areas, where mental health services may be limited.
  • Emergence of New Drug Options: The introduction of new pharmacological options like aripiprazole, a second-generation antipsychotic, has expanded the available treatments for OCD. These drugs are typically used in combination with SSRIs and have shown promise in reducing OCD symptoms, particularly in patients with severe cases. The development of these new options provides doctors with more tools to treat patients with different forms of OCD.
  • Improved Access to Mental Health Services: Increased awareness and efforts to improve mental health services are resulting in better access to OCD treatments worldwide. Governments and healthcare organizations are working to reduce barriers to care by providing funding, expanding insurance coverage, and training more mental health professionals. This increased access is essential for addressing the growing number of individuals seeking treatment for OCD.

These key developments are making it easier for patients to find effective treatments for OCD. With the introduction of new medications, personalized treatment strategies, and digital health solutions, patients have more options than ever before. These developments are improving overall outcomes for OCD patients and expanding access to care.

Strategic Growth Opportunities in the Obsessive-Compulsive Disorder Medicine Market

The obsessive-compulsive disorder medicine market presents numerous growth opportunities driven by innovations in treatment options, increasing patient awareness, and improvements in healthcare infrastructure. Companies in the market have the chance to capitalize on these opportunities by focusing on unmet needs and expanding access to effective treatments.

  • Expanding Digital Health Solutions: Digital health solutions, including apps for symptom tracking, virtual therapy sessions, and wearable devices, represent a key growth opportunity. These tools are becoming increasingly popular for managing OCD, especially in remote areas. Companies that develop or invest in digital health platforms can tap into the growing demand for accessible and cost-effective treatment options.
  • Introduction of Combination Therapies: Combination therapies that integrate pharmacological treatments with cognitive behavioral therapy (CBT) are gaining traction. This integrated approach is particularly effective for individuals with severe or treatment-resistant OCD. Companies that focus on developing and marketing these combination therapies can address a significant unmet need in the market, providing more comprehensive care.
  • Personalized Medicine and Biomarker Development: Personalized medicine is a growing trend in mental health treatment, including OCD. Developing biomarkers to predict treatment responses and guide personalized treatment strategies presents a valuable growth opportunity. Companies that focus on this area can develop tailored therapies that are more effective, reducing the trial-and-error approach currently prevalent in OCD treatment.
  • Expanding Access to Care in Emerging Markets: The OCD medicine market is poised for significant growth in emerging markets, particularly in Asia and Latin America. Increased awareness of mental health issues and improved healthcare infrastructure are driving demand for mental health treatments in these regions. Companies that focus on providing affordable and effective OCD treatments will benefit from this expanding market.
  • Focus on New Drug Development: The continued development of new drugs, including fast-acting medications and those for treatment-resistant OCD, presents a substantial growth opportunity. With regulatory agencies approving more innovative treatments, pharmaceutical companies can expand their product portfolios, improving patient outcomes and capturing larger market shares.

These growth opportunities are expected to drive significant advancements in the OCD medicine market. Companies that capitalize on these trends will help shape the future of OCD treatment by offering more accessible, personalized, and effective solutions to patients worldwide.

Obsessive-Compulsive Disorder Medicine Market Driver and Challenges

The obsessive-compulsive disorder medicine market is influenced by a combination of drivers and challenges, including technological advancements, increasing patient demand, and regulatory hurdles. Understanding these factors is essential for navigating the market and developing effective solutions for OCD.

The factors responsible for driving the obsessive-compulsive disorder medicine market include:

1. Advancements in Drug Development: Continued innovation in the development of new medications for OCD is a major driver of market growth. New drugs, including esketamine and aripiprazole, are offering more treatment options for patients, particularly those with treatment-resistant OCD.

2. Increasing Awareness of Mental Health: Growing awareness of mental health issues is leading to better recognition and diagnosis of OCD. As more people understand the symptoms of OCD, the demand for effective treatments is rising, driving market growth.

3. Improvements in Healthcare Access: Expanding healthcare infrastructure, particularly in emerging markets, is improving access to OCD treatments. As more people seek care, the market for OCD medications continues to grow.

4. Shift Toward Personalized Medicine: Personalized medicine is becoming a key trend in OCD treatment, with healthcare providers tailoring therapies to individual patient needs. This shift is driving demand for customized treatment options and improving outcomes.

5. Government Support for Mental Health: Governments worldwide are increasing funding for mental health programs, including those focused on OCD. These initiatives are helping to improve diagnosis, treatment access, and awareness, contributing to market growth.

Challenges in the obsessive-compulsive disorder medicine market are:

1. High Treatment Costs: The cost of new medications, especially biologics and combination therapies, is a significant challenge for patients, especially in lower-income regions. High treatment costs limit access to care and hinder market expansion.

2. Limited Availability of Specialized Care: In many regions, there is a lack of specialized care for OCD, including trained therapists and access to advanced treatments. This creates barriers for patients seeking effective care, limiting the market's potential.

3. Stigma Around Mental Health: Despite increased awareness, the stigma surrounding mental health conditions like OCD persists in certain cultures. This stigma can prevent individuals from seeking treatment, limiting the growth of the OCD medicine market.

The OCD medicine market is growing due to advancements in treatment options, increased awareness, and improving healthcare access. However, challenges like high costs, limited specialized care, and stigma remain significant barriers. Addressing these challenges will be crucial for unlocking the full potential of the market.

List of Obsessive-Compulsive Disorder Medicine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, obsessive-compulsive disorder medicine companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the obsessive-compulsive disorder medicine companies profiled in this report include:

  • Sun Pharmaceuticals Industry
  • H. Lunderbeck A/S
  • Eli Lilly and Company
  • Apotex
  • Viatris
  • Lannett
  • GlaxoSmithKline
  • Alvogen
  • Pfizer
  • Amneal Pharmaceuticals

Obsessive-Compulsive Disorder Medicine Market by Segment

The study includes a forecast for the global obsessive-compulsive disorder medicine market by type, application, and region.

Obsessive-Compulsive Disorder Medicine Market by Type [Value from 2019 to 2031]:

  • NMDA Receptor Blockers
  • Antipsychotics
  • Antidepressants

Obsessive-Compulsive Disorder Medicine Market by Application [Value from 2019 to 2031]:

  • Hospitals
  • Homecare
  • Clinics
  • Others

Obsessive-Compulsive Disorder Medicine Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Obsessive-Compulsive Disorder Medicine Market

Obsessive-compulsive disorder medicine market is a chronic mental health condition marked by persistent, unwanted thoughts (obsessions) and repetitive behaviors (compulsions). The global OCD medicine market has evolved with new medications and therapies aimed at improving the quality of life for individuals suffering from this condition. Significant advancements have been made in pharmacological treatments, including selective serotonin reuptake inhibitors (SSRIs) and new generation drugs. Additionally, growing awareness of mental health and increasing availability of personalized treatments are accelerating market growth. The United States, China, Germany, India, and Japan have each seen unique developments in the OCD medicine market that cater to both the rising demand and the need for better treatment solutions.

  • United States: In the United States, the OCD medicine market has seen a surge in demand, driven by increased awareness and more advanced treatment options. Recent approvals of medications like esketamine (a nasal spray for treatment-resistant OCD) have introduced new avenues for patients who do not respond to traditional SSRIs. Cognitive behavioral therapy (CBT) integrated with pharmaceutical treatments continues to be the gold standard in treating OCD. The market is also witnessing a rise in research focusing on novel drug formulations, as well as the development of digital tools like apps for monitoring symptoms and enhancing treatment adherence.
  • China: China is making strides in expanding its OCD medicine market as mental health issues gain recognition. Traditional SSRIs are the first-line treatment in the country, though the introduction of newer drugs such as clomipramine and serotonin-norepinephrine reuptake inhibitors (SNRIs) is slowly changing the landscape. The Chinese government has been investing in improving mental health services and access to medications, but the treatment for OCD is still in its early stages compared to Western nations. Cultural factors also affect how OCD is perceived and diagnosed, influencing market growth in the region.
  • Germany: Germany has one of the most well-established healthcare systems in Europe and is a leader in the development and approval of new treatments for OCD. The use of SSRIs such as fluoxetine and sertraline remains widespread, but more specialized medications like selective serotonin-norepinephrine reuptake inhibitors (SSNRIs) are increasingly used. Additionally, the country is investing in research on gene therapy and novel psychiatric treatments. Germany's healthcare providers also incorporate cognitive behavioral therapy (CBT) as a complementary treatment alongside medications, a dual approach that has improved outcomes for many patients suffering from OCD.
  • India: In India, the OCD medicine market is evolving, though it faces challenges due to limited access to newer medications and mental health treatments. SSRIs like fluoxetine are commonly prescribed, but newer treatments are often less accessible due to cost and availability. However, awareness of mental health conditions, including OCD, is increasing due to educational campaigns and government initiatives. India is beginning to explore the integration of pharmacological treatments with digital tools, such as telemedicine and mobile health apps, to improve diagnosis and treatment adherence in rural areas.
  • Japan: The Japanese OCD medicine market has been shaped by the integration of advanced psychiatric treatments with traditional practices. SSRIs remain the cornerstone of treatment in Japan, though newer drugs like aripiprazole and esketamine are gaining traction, especially for treatment-resistant cases. The country also emphasizes a holistic approach that combines medication with cognitive behavioral therapy. With Japan's well-developed healthcare infrastructure, patients have better access to cutting-edge treatments. Additionally, Japan's government has been investing in mental health awareness programs, helping to reduce the stigma associated with OCD and increasing demand for medical solutions.

Features of the Global Obsessive-Compulsive Disorder Medicine Market

  • Market Size Estimates: Obsessive-compulsive disorder medicine market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Obsessive-compulsive disorder medicine market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Obsessive-compulsive disorder medicine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the obsessive-compulsive disorder medicine market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the obsessive-compulsive disorder medicine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the obsessive-compulsive disorder medicine market by type (NMDA receptor blockers, antipsychotics, and antidepressants), application (hospitals, homecare, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Obsessive-Compulsive Disorder Medicine Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 NMDA Receptor Blockers: Trends and Forecast (2019-2031)
  • 4.4 Antipsychotics: Trends and Forecast (2019-2031)
  • 4.5 Antidepressants: Trends and Forecast (2019-2031)

5. Global Obsessive-Compulsive Disorder Medicine Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospitals: Trends and Forecast (2019-2031)
  • 5.4 Homecare: Trends and Forecast (2019-2031)
  • 5.5 Clinics: Trends and Forecast (2019-2031)
  • 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Obsessive-Compulsive Disorder Medicine Market by Region

7. North American Obsessive-Compulsive Disorder Medicine Market

  • 7.1 Overview
  • 7.2 North American Obsessive-Compulsive Disorder Medicine Market by Type
  • 7.3 North American Obsessive-Compulsive Disorder Medicine Market by Application
  • 7.4 United States Obsessive-Compulsive Disorder Medicine Market
  • 7.5 Mexican Obsessive-Compulsive Disorder Medicine Market
  • 7.6 Canadian Obsessive-Compulsive Disorder Medicine Market

8. European Obsessive-Compulsive Disorder Medicine Market

  • 8.1 Overview
  • 8.2 European Obsessive-Compulsive Disorder Medicine Market by Type
  • 8.3 European Obsessive-Compulsive Disorder Medicine Market by Application
  • 8.4 German Obsessive-Compulsive Disorder Medicine Market
  • 8.5 French Obsessive-Compulsive Disorder Medicine Market
  • 8.6 Spanish Obsessive-Compulsive Disorder Medicine Market
  • 8.7 Italian Obsessive-Compulsive Disorder Medicine Market
  • 8.8 United Kingdom Obsessive-Compulsive Disorder Medicine Market

9. APAC Obsessive-Compulsive Disorder Medicine Market

  • 9.1 Overview
  • 9.2 APAC Obsessive-Compulsive Disorder Medicine Market by Type
  • 9.3 APAC Obsessive-Compulsive Disorder Medicine Market by Application
  • 9.4 Japanese Obsessive-Compulsive Disorder Medicine Market
  • 9.5 Indian Obsessive-Compulsive Disorder Medicine Market
  • 9.6 Chinese Obsessive-Compulsive Disorder Medicine Market
  • 9.7 South Korean Obsessive-Compulsive Disorder Medicine Market
  • 9.8 Indonesian Obsessive-Compulsive Disorder Medicine Market

10. ROW Obsessive-Compulsive Disorder Medicine Market

  • 10.1 Overview
  • 10.2 ROW Obsessive-Compulsive Disorder Medicine Market by Type
  • 10.3 ROW Obsessive-Compulsive Disorder Medicine Market by Application
  • 10.4 Middle Eastern Obsessive-Compulsive Disorder Medicine Market
  • 10.5 South American Obsessive-Compulsive Disorder Medicine Market
  • 10.6 African Obsessive-Compulsive Disorder Medicine Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Obsessive-Compulsive Disorder Medicine Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Sun Pharmaceuticals Industry
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 H.Lunderbeck A/S
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Eli Lilly And Company
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Apotex
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Viatris
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Lannett
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 GlaxoSmithKline
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Alvogen
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Pfizer
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.11 Amneal Pharmaceuticals
    • Company Overview
    • Obsessive-Compulsive Disorder Medicine Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Obsessive-Compulsive Disorder Medicine Market
  • Figure 2.1: Usage of Obsessive-Compulsive Disorder Medicine Market
  • Figure 2.2: Classification of the Global Obsessive-Compulsive Disorder Medicine Market
  • Figure 2.3: Supply Chain of the Global Obsessive-Compulsive Disorder Medicine Market
  • Figure 2.4: Driver and Challenges of the Obsessive-Compulsive Disorder Medicine Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 4.1: Global Obsessive-Compulsive Disorder Medicine Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Obsessive-Compulsive Disorder Medicine Market ($B) by Type
  • Figure 4.3: Forecast for the Global Obsessive-Compulsive Disorder Medicine Market ($B) by Type
  • Figure 4.4: Trends and Forecast for NMDA Receptor Blockers in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Antipsychotics in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 4.6: Trends and Forecast for Antidepressants in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 5.1: Global Obsessive-Compulsive Disorder Medicine Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Obsessive-Compulsive Disorder Medicine Market ($B) by Application
  • Figure 5.3: Forecast for the Global Obsessive-Compulsive Disorder Medicine Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospitals in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Homecare in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Clinics in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 5.7: Trends and Forecast for Others in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 6.1: Trends of the Global Obsessive-Compulsive Disorder Medicine Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Obsessive-Compulsive Disorder Medicine Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 7.2: North American Obsessive-Compulsive Disorder Medicine Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Obsessive-Compulsive Disorder Medicine Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Obsessive-Compulsive Disorder Medicine Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Obsessive-Compulsive Disorder Medicine Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Obsessive-Compulsive Disorder Medicine Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Obsessive-Compulsive Disorder Medicine Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 8.2: European Obsessive-Compulsive Disorder Medicine Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Obsessive-Compulsive Disorder Medicine Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Obsessive-Compulsive Disorder Medicine Market ($B) by Type (2025-2031)
  • Figure 8.5: European Obsessive-Compulsive Disorder Medicine Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Obsessive-Compulsive Disorder Medicine Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Obsessive-Compulsive Disorder Medicine Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 9.2: APAC Obsessive-Compulsive Disorder Medicine Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Obsessive-Compulsive Disorder Medicine Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Obsessive-Compulsive Disorder Medicine Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Obsessive-Compulsive Disorder Medicine Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Obsessive-Compulsive Disorder Medicine Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Obsessive-Compulsive Disorder Medicine Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Figure 10.2: ROW Obsessive-Compulsive Disorder Medicine Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Obsessive-Compulsive Disorder Medicine Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Obsessive-Compulsive Disorder Medicine Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Obsessive-Compulsive Disorder Medicine Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Obsessive-Compulsive Disorder Medicine Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Obsessive-Compulsive Disorder Medicine Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Obsessive-Compulsive Disorder Medicine Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Obsessive-Compulsive Disorder Medicine Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Obsessive-Compulsive Disorder Medicine Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Obsessive-Compulsive Disorder Medicine Market by Type
  • Figure 12.2: Growth Opportunities for the Global Obsessive-Compulsive Disorder Medicine Market by Application
  • Figure 12.3: Growth Opportunities for the Global Obsessive-Compulsive Disorder Medicine Market by Region
  • Figure 12.4: Emerging Trends in the Global Obsessive-Compulsive Disorder Medicine Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Obsessive-Compulsive Disorder Medicine Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Obsessive-Compulsive Disorder Medicine Market by Region
  • Table 1.3: Global Obsessive-Compulsive Disorder Medicine Market Parameters and Attributes
  • Table 3.1: Trends of the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 3.2: Forecast for the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Obsessive-Compulsive Disorder Medicine Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 4.4: Trends of NMDA Receptor Blockers in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 4.5: Forecast for NMDA Receptor Blockers in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 4.6: Trends of Antipsychotics in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 4.7: Forecast for Antipsychotics in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 4.8: Trends of Antidepressants in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 4.9: Forecast for Antidepressants in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Obsessive-Compulsive Disorder Medicine Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 5.4: Trends of Hospitals in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 5.5: Forecast for Hospitals in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 5.6: Trends of Homecare in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 5.7: Forecast for Homecare in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 5.8: Trends of Clinics in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 5.9: Forecast for Clinics in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 5.10: Trends of Others in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 5.11: Forecast for Others in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 7.1: Trends of the North American Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 7.2: Forecast for the North American Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 8.1: Trends of the European Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 8.2: Forecast for the European Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 9.1: Trends of the APAC Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 9.2: Forecast for the APAC Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 10.1: Trends of the ROW Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 10.2: Forecast for the ROW Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Obsessive-Compulsive Disorder Medicine Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Obsessive-Compulsive Disorder Medicine Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Obsessive-Compulsive Disorder Medicine Market (2019-2031)
  • Table 11.1: Product Mapping of Obsessive-Compulsive Disorder Medicine Suppliers Based on Segments
  • Table 11.2: Operational Integration of Obsessive-Compulsive Disorder Medicine Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Obsessive-Compulsive Disorder Medicine Revenue
  • Table 12.1: New Product Launches by Major Obsessive-Compulsive Disorder Medicine Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Obsessive-Compulsive Disorder Medicine Market